ABCB1 Variation Affects Myelosuppression, Progression ‐free Survival and Overall Survival in Paclitaxel/Carboplatin‐treated Ovarian Cancer Patients
This article is protected by copyright. All rights reserved.
Source: Basic and Clinical Pharmacology and Toxicology - Category: Drugs & Pharmacology Authors: Niclas Bj örn, Ingrid Jakobsen Falk, Ignace Vergote, Henrik Gréen Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Ovarian Cancer | Ovaries | Study | Toxicology